New drug applications for central nervous system (CNS) therapy made up for around 95 of the new drug applications filed by Aurobindo Pharma as of financial year 2019. New drug applications for cardiovascular diseases followed with almost 84 percent of the total ANDAs that year.
Number of abbreviated new drug applications by Aurobindo Pharma Limited in financial year 2019, by therapy
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
Selected statistics
1
Other regions
10
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Premium Statistic Number of Indian ANDA approvals by the U.S. FDA 2017-2019
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
- Premium Statistic Volume of medicines dispensed in pharmacies reimbursed in France 2014, by class
- Basic Statistic Top indications for new brand drug approvals in Canada in 2018
- Premium Statistic Sales volume of the largest-selling prescription drugs in Spain 2019-2020
- Premium Statistic Sales of pharmaceutical drugs Thailand 2021, by type
- Premium Statistic Domestic partnership deals in China's pharma industry 2013-2021
- Premium Statistic Number of diabetics receiving health care in Italy 2018, by treatment
- Premium Statistic Pneumococcal vaccine immunization rate in Scotland 2008-2022
Related statistics
10
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Rate of approval for Indian pharma ANDA by U.S. FDA 2017-2019
- Premium Statistic India's public expenditure on health as a share of GDP FY 2010-2020
- Premium Statistic Apollo hospitals' occupancy rate FY 2014-2023
- Premium Statistic Fortis Healthcare's occupancy rate FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' revenue share from operations in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' shareholder distribution India FY 2023
- Premium Statistic GSK Pharmaceuticals' profit before tax in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
Further related statistics
9
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1950-2019
Further Content: You might find this interesting as well
Statistics
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1950-2019
Aurobindo Pharma. (August 2, 2019). Number of abbreviated new drug applications by Aurobindo Pharma Limited in financial year 2019, by therapy [Graph]. In Statista. Retrieved March 28, 2024, from https://www.statista.com/statistics/996022/india-aurobindo-pharma-anda-portfolio/
Aurobindo Pharma. "Number of abbreviated new drug applications by Aurobindo Pharma Limited in financial year 2019, by therapy." Chart. August 2, 2019. Statista. Accessed March 28, 2024. https://www.statista.com/statistics/996022/india-aurobindo-pharma-anda-portfolio/
Aurobindo Pharma. (2019). Number of abbreviated new drug applications by Aurobindo Pharma Limited in financial year 2019, by therapy. Statista. Statista Inc.. Accessed: March 28, 2024. https://www.statista.com/statistics/996022/india-aurobindo-pharma-anda-portfolio/
Aurobindo Pharma. "Number of Abbreviated New Drug Applications by Aurobindo Pharma Limited in Financial Year 2019, by Therapy." Statista, Statista Inc., 2 Aug 2019, https://www.statista.com/statistics/996022/india-aurobindo-pharma-anda-portfolio/
Aurobindo Pharma, Number of abbreviated new drug applications by Aurobindo Pharma Limited in financial year 2019, by therapy Statista, https://www.statista.com/statistics/996022/india-aurobindo-pharma-anda-portfolio/ (last visited March 28, 2024)
Number of abbreviated new drug applications by Aurobindo Pharma Limited in financial year 2019, by therapy [Graph], Aurobindo Pharma, August 2, 2019. [Online]. Available: https://www.statista.com/statistics/996022/india-aurobindo-pharma-anda-portfolio/